Literature DB >> 8557879

Imipenem/cilastin dosage during acute renal failure and hemofiltration.

M G Dehne, U F Kroh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8557879     DOI： 10.1007/bf01700974

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  3 in total

1.  Single-dose kinetics of imipenem/cilastatin during continuous arteriovenous haemofiltration in intensive care patients.

Authors:  E Keller; H Fecht; J Böhler; P Schollmeyer
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992

2.  Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD).

Authors:  M C Vos; H H Vincent; E P Yzerman
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 3.  An overview of the pharmacology of imipenem/cilastatin.

Authors:  G L Drusano
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790
  3 in total
  2 in total

Review 1.  Comparative pharmacokinetics of the carbapenems: clinical implications.

Authors:  J W Mouton; D J Touzw; A M Horrevorts; A A Vinks
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

2.  Using imipenem and cilastatin during continuous renal replacement therapy.

Authors:  Alison Cotton; Bryony Dean Franklin; Stephen Brett; Alison Holmes
Journal:  Pharm World Sci       Date:  2005-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.